These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1972932)

  • 21. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
    Lee EY; Cibull ML; Strodel WE; Haley JV
    Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the placenta.
    Wang DP; Fujii S; Konishi I; Nanbu Y; Iwai T; Nonogaki H; Mori T
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):385-93. PubMed ID: 1375794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate.
    Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE
    J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS; Ruby SG; Weinberg DS; Chin D; Ortiz R; Bacus JW
    Am J Pathol; 1990 Jul; 137(1):103-11. PubMed ID: 1973597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
    Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
    J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma membrane phosphotyrosine, Her2-NEU, and epidermal growth factor receptor in human breast cancer. A comparative study.
    Heffelfinger SC; Lower EE; Miller MA; Fenoglio-Preiser CM
    Am J Clin Oncol; 1996 Dec; 19(6):552-7. PubMed ID: 8931669
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma.
    Jaehne J; Urmacher C; Thaler HT; Friedlander-Klar H; Cordon-Cardo C; Meyer HJ
    J Cancer Res Clin Oncol; 1992; 118(6):474-9. PubMed ID: 1352299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
    Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
    In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of p185 is not related to erbB2 amplification in ovarian cancer.
    Morali F; Cattabeni M; Tagliabue E; Campiglio M; Menard S; Marzola M; Lucchini V; Colombo N; Mangioni C; Redaelli L
    Ann Oncol; 1993 Nov; 4(9):775-9. PubMed ID: 7904177
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast.
    Möller P; Mechtersheimer G; Kaufmann M; Moldenhauer G; Momburg F; Mattfeldt T; Otto HF
    Virchows Arch A Pathol Anat Histopathol; 1989; 414(2):157-64. PubMed ID: 2464868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous immunoreactivity of frozen human benign and malignant breast lesions to C-MYC and C-Ha-ras cellular oncogenes.
    Pechoux C; Chardonnet Y; Chignol MC; Noël P
    Histol Histopathol; 1994 Jan; 9(1):35-44. PubMed ID: 8003818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor.
    Poller DN; Hutchings CE; Galea M; Bell JA; Nicholson RA; Elston CW; Blamey RW; Ellis IO
    Br J Cancer; 1992 Sep; 66(3):583-8. PubMed ID: 1355662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study.
    Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP
    Prostate; 1993; 23(4):329-36. PubMed ID: 7505056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and patterns of staining of Neu oncogene product in benign and malignant breast diseases.
    Hanna W; Kahn HJ; Andrulis I; Pawson T
    Mod Pathol; 1990 Jul; 3(4):455-61. PubMed ID: 1977159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the c-erbB2 proto-oncogene in male breast carcinoma: lack of prognostic significance.
    Blin N; Kardaś I; Welter C; Ryś J; Niezabitowski A; Limon J; Seitz G
    Oncology; 1993; 50(6):408-11. PubMed ID: 7901823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunosorbent assay of HER-2/neu gene product (p185) in breast cancer: its correlation with sex steroid receptors, cathepsin D and histologic grades.
    Marsigliante S; Muscella A; Ciardo V; Barker S; Leo G; Baker V; Mottaghi A; Vinson GP; Storelli C
    Cancer Lett; 1993 Dec; 75(3):195-206. PubMed ID: 7906196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation.
    Chiu KY; Loke SL; Ho FC
    J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparameter flow-cytometric quantitation of epidermal growth factor receptor and c-erbB-2 oncoprotein in normal and neoplastic tissues of the female genital tract.
    van Dam PA; Lowe DG; Watson JV; James M; Chard T; Hudson CN; Shepherd JH
    Gynecol Oncol; 1991 Sep; 42(3):256-64. PubMed ID: 1683331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-erbB-3 and c-erbB-2 protein expression in node-negative breast carcinoma--an immunocytochemical study.
    Gasparini G; Gullick WJ; Maluta S; Dalla Palma P; Caffo O; Leonardi E; Boracchi P; Pozza F; Lemoine NR; Bevilacqua P
    Eur J Cancer; 1994; 30A(1):16-22. PubMed ID: 7908213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.